DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20205798

Hepatocellular carcinoma associated with pregnancy about 2 cases at the gynecological and obstetrical clinic of the Aristide Le Dantec hospital, Dakar, Senegal

Abdoulaye Diakhate, Omar Gassama, Mohamed Diadhiou, Simon B. Ndour, Mouhamadou Wade, Daba Diop, Adja M. Wade, Ndama Niang, Mame D. N. Guèye, Mamour Guèye, Jean Charles Moreau

Abstract


The objective of our study was to report 2 cases of hepatocellular carcinomas associated with pregnancy followed in our structure and to review the literature. Our patients were 30 and 37-year-old multi-gesture females with chronic unattended viral hepatitis B in whom the diagnosis of hepatocellular carcinoma was made in the third trimester of pregnancy at 31 weeks of amenorrhea and 4 days and at 32 weeks of amenorrhea after the incidental finding of tumor hepatomegaly on abdominal-pelvic ultrasound. The main clinical signs were jaundice and hepatomegaly and paraclinical signs were dominated by hepatic cytolysis and anemia in addition to ultrasound images. Follow-up of pregnancies revealed no particularities. A caesarean section was scheduled at 32 weeks of amenorrhea and 32 weeks of amenorrhea and 3 days allowing the birth of two preterm newborns weighing 1210 and 1500 gm with Apgar scores of 8-10/10 and 7-9/10 respectively at the fifth minute. The immediate post-operative follow-up was simple. However, the maternal-fetal prognosis was poor with the death of both patients in a multi-visceral failure table occurring respectively at 6 weeks and 3 weeks after caesarean section. The newborns had died 8 days after birth. Although rare, these two cases challenge any obstetrician to think about liver cancer in pregnant women, especially those with chronic hepatitis B. Ultrasound examination of the liver, or even better, the MRI, which is more efficient, in order to suspect early on a possible liver cancer. Indeed, early diagnosis and a thorough medical approach are essential for the treatment of HCC in pregnant patients.


Keywords


Hepatocellular carcinoma, Pregnancy, Liver cancer, Viral hepatitis B

Full Text:

PDF

References


Trichopoulos D. Etiology of primary liver cancer and the role of steroidal hormones (editorial). Cancer Cases Controls. 1992;3:3‑5.

Choi K, Ju Hong Y. Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients? J Hepatobiliary Pancreat Sci. 18:422‑31.

Egwuatu V. Primary hepatocarcinoma in pregnancy. Trans Royal Soc Trop Med Hyg prednancy. 1980;74:793‑4.

Alison M. Liver Stem Cells: Implications for hepato- carcinogenesis. Stem Cells Rev. 2005;1(3):253‑60.

Lau W, Leng W, Ho S. Hepatocellular Carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer. 1995;75:2669‑76.

Ndubuda D, Makinde O, Ojo O. Hepatocellular carcinoma in pregnancy and postpartum period: a study of 6 cases in Nigerian women. J Clin Pract. 2004;7:46‑9.

Esike Chidi O, Ezeonu Paul O, Umeora Odidika U. Le carcinome hépatocellulaire pendant la grossesse, un cancer rare qui survient encore pendant la grossesse-une revue de la littérature. Int J Clin Obstet Gynaecol. 2020;4(2):04‑6.

Lee H, Kim C. Association étiologique prédominante du virus de l’hépatite C avec le carcinome hépatocellulaire par rapport au virus de l’hépatite B chez les patients âgés dans une zone d’endémie de l’hépatite B. Cancer. 1993;72:2564-7.

Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterol. 1977;73:386-94.

Heinemann L, DoMinh T, Guggenmoos-Holzmann I. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). Contracep. 1997;56:275‑84.

Alireza N, Mohammad N. Hepatocellular carcinoma in pregnancy with unusual presentations. Middle East J Dig DIS. 2012;4(4):228‑31.

Lai E, Lai P, Lau W. Soft tissue case 52. Hepatocellular carcinoma with tumour cast in the biliary tree. Canad J Surg. 2003;46:301‑11.

Russell P, Sanjay P, Dirkzwager I. Carcinome hépatocellulaire pendant la grossesse: étude de cas et revue de la littérature. Journal médical de Nouvelle-Zélande. 2012;125:1353.

La vecchia C, Altieri A, Franceschi S, Tavani A. Oral contraceptives and cancer: An update. Drug Safety. 2001;24:741‑54.

Sherman M. Alphafetoprotein: une nécrologie. J hepatol. 2001;34:603‑5.

Trevisani F, D’Intino P. Alpha-foetoprotéine sérique pour le diagnostic nez de carcinome hépatocellulaire chez les patients atteints de foie chronique maladie: influence de l’HBsAg et du statut anti-VHC. J hepatol. 2001;34:570‑5.

Seppl M. Alpha dans le sérum maternel: a nouveau marqueur pour la détection de la détresse foetale et de la mort intra-utérine. Suis J Obstet Gynecol. 1973;115:48‑52.

Caballero C, Vekemans M, Lopez del Campo J. Alpha-foetoprotéine sérique chez l’adulte, la femme pendant la grossesse, enfants à la naissance et pendant la première semaine de vie: une différence de sexe. Suis J Obstet Gynecol. 1977;127:384‑9.

Mizejewski G. Niveaux d’alpha-foetoprotéine pendant la grossesse et petite enfance dans les états normaux et pathologiques. Obstet Gynecol Surv. 2003;58:804‑26.

Lee H, Chung Y, Kim C. Spécificités de l’alpha sérique fétoprotéine dans HBsAgS+ et HBsAg- patients dans le diagnostic de carcinome hépatocellulaire. Hépatologie. 1991;14:68‑72.

Ai-Jun L, Wei-Ping Z, Jun-hau L. Surgery for pregnancy–associated primary hepatocellular carcinoma. Report of four cases. Int J Surg Case Reports. 2014;5(2):882‑5.

Cobey F, Salem R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg. 2004;187:181‑91.

El-Serag H. Carcinome hépatocellulaire. N Engl J Med. 2011;365(111):8‑27.

Jonas M. Hepatitis B. pregnancy: an underestimated issue. Liver Int. 2009;29:133‑9.

Jeng L, Lee W, Wang C. Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein. Am J Obstet Gynecol. 1995;172:219‑20.

Gisi P, Floyd R. Hepatocellular carcinoma in pregnancy. case reports. J Reprod Med. 1999;44:65‑7.

De la Rosa M, Nicols-Prez D, Muiz-Montes J. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res. 2006;32:437‑9.